Quick Answer
Quoin Pharmaceuticals, Ltd. reported Shares Outstanding of 52.44 million shares for fiscal year 2025.
Quoin Pharmaceuticals, Ltd. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 52.44M | +486.1% |
| 2024 | 8.95M | +806.4% |
| 2023 | 987,220 | +144.4% |
| 2022 | 403,887 | -100.0% |
| 2021 | 3.35B | +179.2% |
| 2020 | 1.20B | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 20.59M | +307.7% | +0.0% |
| June 30, 2025 | 20.59M | +417.2% | +0.0% |
| March 31, 2025 | 20.59M | +442.3% | +130.1% |
| December 31, 2024 | 8.95M | +806.4% | +77.2% |
| September 30, 2024 | 5.05M | +411.5% | +26.9% |
| June 30, 2024 | 3.98M | -100.0% | +4.8% |
| March 31, 2024 | 3.80M | -100.0% | +284.5% |
| December 31, 2023 | 987,220 | +144.4% | +0.0% |
- Quoin Pharmaceuticals, Ltd. showed an increase of +486.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Quoin Pharmaceuticals, Ltd.’s shares outstanding has declined by 95.6% (from 1.20 billion shares to 52.44 million shares).
- The most recent figure is from Quoin Pharmaceuticals, Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: